<SEC-DOCUMENT>0001594062-22-000024.txt : 20220317
<SEC-HEADER>0001594062-22-000024.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317084354
ACCESSION NUMBER:		0001594062-22-000024
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220316
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Flora Growth Corp.
		CENTRAL INDEX KEY:			0001790169
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40397
		FILM NUMBER:		22746900

	BUSINESS ADDRESS:	
		STREET 1:		198 DAVENPORT ROAD
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5R 1J2
		BUSINESS PHONE:		416-861-2267

	MAIL ADDRESS:	
		STREET 1:		198 DAVENPORT ROAD
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5R 1J2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: The Ideal Connection
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div><br>
    </div>
    <div>
      <div>
        <div style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      </div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-weight: bold;">WASHINGTON, D.C. 20549</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; font-weight: bold;">PURSUANT TO RULE 13a-16 OR 15d-16</div>
      <div style="text-align: center; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">For the month of March 2022</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Commission File Number 001-40397</div>
      <div>&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FLORA GROWTH CORP.</div>
      <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">198 Davenport Road</div>
        <div style="text-align: center;"><font style="font-weight: bold;">Toronto, Ontario M5R 1J2, Canada</font></div>
      </div>
      <div style="text-align: center;">(Address of Principal Executive Offices)</div>
      <div>&#160;</div>
      <div>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</div>
      <div>&#9746; Form 20-F &#9723; Form 40-F</div>
      <div>&#160;</div>
      <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9723;</div>
      <div>&#160;</div>
      <div><font style="font-weight: bold;">Note</font>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</div>
      <div><br>
      </div>
      <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9723;</div>
      <div><br>
      </div>
      <div><font style="font-weight: bold;">Note</font>: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make
        public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on which the registrant&#8217;s securities are traded, as
        long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or
        other Commission filing on EDGAR.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      </div>
      <div><br>
      </div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt; font-size: 12pt; font-weight: bold;">INFORMATION CONTAINED IN THIS FORM 6-K REPORT</div>
      <div style="text-align: center; margin-bottom: 10pt; font-weight: bold;">Resignation of Director; Appointment of Director</div>
      <div style="text-align: justify; margin-bottom: 10pt;">On March 10, 2022, Dr. Bernard Wilson resigned from the Board of Directors (the &#8220;<u>Board</u>&#8221;) of Flora Growth Corp., a company incorporated in the Province of Ontario (the &#8220;<u>Company</u>&#8221;), effective immediately upon notice. In connection with Dr. Wilson&#8217;s resignation, Dr. Wilson also resigned from his position as a member and Chairman of the Audit Committee of
        the Board (the &#8220;<u>Audit Committee</u>&#8221;). Dr. Wilson&#8217;s resignation from the Board was not due to any disagreements with the Company or the Board.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">In connection with Dr. Wilson&#8217;s resignation, effective March 15, 2022, the Board appointed Luis Merchan, the Company&#8217;s current Chief
        Executive Officer and Director, as Chairman of the Board.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">Following Dr. Wilson&#8217;s resignation, on March 15, 2022, the Company entered into a consulting agreement with Dr. Wilson. Under the
        consulting agreement, Mr. Wilson has agreed to provide special advisory services to the Company&#8217;s Chief Executive Officer and the Board through December 31, 2022 in exchange for compensation of $25,000 per month. The consulting agreement may be
        terminated by either party at any time, subject to certain conditions.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">In addition, effective March 15, 2022, the Board appointed John Timothy (&#8220;Tim&#8221;) Leslie as a Director and member of the Audit
        Committee to fill the vacancies created by Dr. Wilson&#8217;s resignation. The Board has determined that Mr. Leslie qualifies as an &#8220;audit committee financial expert&#8221; as such term has been defined in Item 407(d)(5) of Regulation S-K and as &#8220;financially
        literate&#8221; within the meaning of NI 52-110. The Board has also determined that Mr. Leslie &#160;meets the definition of &#8220;independent director&#8221; for purposes of serving on the Audit Committee under applicable Nasdaq Stock Market rules, the independence
        standards under Rule 10A-3 of the Exchange Act of 1934, as amended, and under NI 52-110.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">Mr. Leslie currently serves as an Executive in Residence at Beloit College as well as an independent management consultant to large
        technology and retail firms in Latin America and Europe. Prior to his current occupations, Mr. Leslie served as Chief Executive Officer of Leafly Inc., a cannabis information resource and technology company, from February 2019 to September 2020.
        Mr. Leslie also served as Leafly&#8217;s Chairman of the Board from February 2019 to August 2019. Prior to his time at Leafly, Mr. Leslie held various roles at Amazon.com over 20 years, most recently as Vice President, Prime Video International from
        August 2013 to January 2019. Mr. Leslie also currently serves on the Board of Directors of Endocanna Health, Inc., a cannabis health care company, and New Frontier Data, a cannabis business intelligence company. Mr. Leslie received a Bachelor of
        Arts in Economics from Beloit College in 1989 and a Juris Doctor from Yale Law School in 1992.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">Other than as described in this Report on Form 6-K, there are no arrangements or understandings between Mr. Leslie and any other
        person pursuant to which Mr. Leslie was appointed as a Director of the Company.&#160; Since the beginning of the Company&#8217;s last fiscal year, the Company has not engaged in any transaction, or any currently proposed transaction, in which Mr. Leslie had
        or will have a direct or indirect material interest in which the amount involved exceeded or would exceed $120,000.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">A press release announcing the above changes to the Board has been furnished as Exhibit 99.1 hereto.</div>
      <div>
        <div style="text-align: center; font-weight: bold;">Exhibit Index</div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze3299e53fcc44bc189f6b2f3851b86b5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 13%; vertical-align: top;">
              <div>&#160;Exhibit 99.1</div>
            </td>
            <td style="width: 4.38%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 82.62%; vertical-align: top;">
              <div><a href="ex991.htm">Press release of Flora Growth Corp.,
                  dated March 17, 2022.</a></div>
            </td>
          </tr>

      </table>
      <div style="margin-bottom: 10pt;"><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 10pt;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Signatures</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
        authorized.</div>
      <div style="margin-bottom: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4d5a12fd088e47a4b3db64ba7ce14642">

          <tr>
            <td style="width: 7%; vertical-align: middle;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 25%; vertical-align: middle;">&#160;</td>
            <td colspan="1" style="width: 90%; vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div style="font-weight: bold;">FLORA GROWTH CORP.</div>
            </td>
            <td colspan="1" style="width: 90%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: middle;">&#160;</td>
            <td colspan="2" style="vertical-align: middle;">&#160;</td>
            <td colspan="1" style="width: 90%; vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>/s/ Luis Merchan</div>
              </div>
            </td>
            <td colspan="1" style="width: 90%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div>Name: Luis Merchan</div>
            </td>
            <td colspan="1" style="width: 90%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: bottom;">
              <div>&#160;</div>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div>Title: Chief Executive Officer</div>
            </td>
            <td colspan="1" style="width: 90%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: middle;">&#160;</td>
            <td colspan="2" style="vertical-align: middle;">&#160;</td>
            <td colspan="1" style="width: 90%; vertical-align: middle;">&#160;</td>
          </tr>

      </table>
      <div style="margin-bottom: 10pt;">Date:&#160; March 17, 2022</div>
      <div>&#160;</div>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>PRESS RELEASE OF FLORA GROWTH CORP., DATED MARCH 17, 2022.
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: The Ideal Connection
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div><br>
      </div>
      <div style="text-align: center; margin-top: 10pt; margin-bottom: 6pt; font-size: 18pt;">Flora Growth Appoints Former Amazon Executive Tim Leslie to Its Board of Directors and Names CEO Luis Merchan
        Chairman</div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z4d2f8f2d0b5442aa8c7c8aa3e8ff6917" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin: 0px 0px 0px 18pt;">&#9679;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">Flora Growth&#8217;s CEO Luis Merchan is named Chairman of the Board of Directors.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z0b08604ae2204567a8ec955affebf068" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin: 0px 0px 0px 18pt; font-style: italic;">&#9679;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">Tim Leslie, Chairman of Flora&#8217;s Advisory Board, will join the Flora Board of Directors and audit committee.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zea7d5b0478774781bffdda51aac64225" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin: 0px 0px 0px 18pt; font-style: italic;">&#9679;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">Changes to the Board of Directors signal the Company&#8217;s move toward becoming a U.S.-based issuer and will support Flora&#8217;s
                  growth into new international markets.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;"><font style="font-weight: bold;">MIAMI, FLORIDA AND
          TORONTO, ONTARIO &#8211; March 17, 2022</font> -- Flora Growth Corp. (NASDAQ: FLGC) (&#8220;Flora&#8221; or the &#8220;Company&#8221;), a leading all-outdoor cultivator and manufacturer of global
          cannabis products and brands, announced today changes to its Board of Directors (the &#8220;Board&#8221;) including the appointment of CEO Luis Merchan as Chairman of the Board as well as the addition of industry veteran Tim Leslie to the Board and
        audit committee. Merchan has replaced Bernie Wilson as Chairman of the Board. Wilson will remain in an advisory capacity for the remainder of 2022 and will provide strategic guidance on capital markets and international expansion. The changes to
        the Board will further position Flora as a U.S.-based issuer and is expected to increase the Company&#8217;s access to U.S-based investment.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">Flora Chairman and CEO Luis Merchan has been focused on expanding the Company&#8217;s reach within the United States and
        abroad. Through his leadership, Flora has moved from the development stage to a full-scale international distributor and house of brands with operations in more than 12 countries. He has been pivotal in completing recently announced M&amp;A
        transactions with leading hardware manufacturer Vessel and highly regarded wellness company JustCBD, solidifying the path to rapid growth.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">&#8220;I am honored that our Board has entrusted me with this role, and I believe it is a testament to what we have built
        together thus far,&#8221; said Flora Growth CEO and newly appointed Chairman of the Board Luis Merchan. &#8220;Our Board has been incredibly supportive to date while always ensuring business decisions are in the best interest of our shareholders - and I am
        looking forward to continuing to work closely with them in this role.&#8221;</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">A Yale Law graduate, Tim Leslie has a strong pedigree of success, working with scaling companies including his two
        decades at Amazon. Leslie has been Chairman of the Company&#8217;s Advisory Board since the beginning of 2022, where he has utilized his years of experience as CEO of Leafly and as an Amazon executive to help counsel Flora&#8217;s leadership team. As Flora
        continues its rapid, global expansion, Leslie will play a critical role in navigating this hyper-growth phase. In addition to his role as board member, Leslie will also join the Company&#8217;s audit committee.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">These appointments come as former Chairman of the Board, Bernie Wilson, steps down from his role and transitions to
        an advisory capacity to provide Merchan and the Board with strategic counsel, leveraging his insights and tenure in capital markets.&#160; &#8220;We want to thank Bernie for his commitment to the growth of Flora during this formative time for our company and
        look forward to continuing to work with him as we continue to grow,&#8221; added Merchan.</div>
      <div style="margin-top: 10pt; margin-bottom: 6pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt; font-weight: bold;">About Flora Growth Corp.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that is designed
        to deliver one of the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply
        cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social [media] for more information.</div>
      <div style="margin-top: 10pt; margin-bottom: 6pt;">
        <div style="text-align: justify; font-weight: bold;">Investor Relations Contact:</div>
        <div style="text-align: justify;">Evan Veryard</div>
        <div style="text-align: justify;">evan.veryard@floragrowth.com</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-weight: bold;">Public Relations Contact:</div>
        <div style="text-align: justify;">Cassandra Dowell</div>
        <div style="text-align: justify;">+1 (858) 264-6600</div>
        <div style="text-align: justify;">flora@cmwmedia.com</div>
      </div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt; font-weight: bold;">Cautionary Statement Concerning Forward-Looking Statements</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">This document contains forward-looking statements. In addition, from time to time, we or our representatives may
        make forward-looking statements orally or in writing.&#8239; We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us.&#8239; Such forward-looking
        statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; the collaboration with third parties; and our business prospects and opportunities.&#8239; You can identify forward-looking
        statements by those that are not historical in nature, particularly those that use terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;contemplates,&#8221; &#8220;estimates,&#8221; &#8220;believes,&#8221; &#8220;plans,&#8221; &#8220;projected,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; or &#8220;hopes&#8221; or
        the negative of these or similar terms.&#8239; In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing
        market needs; and the competitive environment of our business.&#8239; These and other factors may cause our actual results to differ materially from any forward-looking statement.&#8239; Forward-looking statements are only predictions.&#8239; The forward-looking
        events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us.&#8239; We
        undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or
        our representatives not occurring, except as may be required by applicable law.</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
